Researchers presented an exploratory analysis comparing OCT biomarkers in a Phase 1b study of ONL1204 in patients with ...

The Food and Drug Administration has granted Fast Track designation to urcosimod for the treatment of neuropathic corneal pain.

Investigators developed a novel severity scoring system for age-related macular degeneration that can generate distinct scores for exudative and nonexudative AMD.

More than 75,000 cases comprising more than 1.8 million cartons of consumer level dry eye drops have been voluntarily recalled.

Reproxalap ophthalmic solution 0.25% reached the primary endpoint in a second phase 3 dry eye chamber trial, according to Aldeyra Therapeutics.

The Trump administration has canceled more than $800 million in research focused on LGBTQ health, cutting hundreds of studies on cancer, HIV and other diseases that affect sexual and gender minority ...

Researchers reviewed the need for supplemental aflibercept injections and overall treatment burden in eyes being treated for ...

In years 3 and 4 of treatment, faricimab was well tolerated with low rates of intraocular inflammation (1.3%) and resulted in ...

A novel tear-based assay can non-invasively differentiate ocular surface squamous neoplasia (OSSN) from pterygium (PTG), ...

Researchers explored the potential for microaneurysms to serve as a surrogate biomarker for the presence of intraretinal ...

Researchers reviewed the potential for links between age-related macular degeneration and immune-mediated inflammatory ...

Researchers evaluated real-world data to extend treatment intervals, maintain BCVA, and achieve macular fluid resolution ...